Asthma Bronchoscopy Study

What we are studying

The purpose of this study is to learn whether the study drug lebrikizumab decreases the amount of abnormal immune response (“inflammation”) in the lungs of patients with asthma.

Who we are studying

  • Men and Women
  • Races:
    • White
    • African American
    • Asian
    • American Indian or Alaska Native
    • Native Hawaiian or Pacific Islander
    • Other
  • All Ethnicities
  • Ages 18 - 75

Eligibility Criteria

  • Diagnosed with asthma
  • Non-Smoker (less than 100 cigarettes in your lifetime)
  • Using an inhaler steroid
  • Using a secondary controller medication
  • Be willing to have a bronchoscopy

What is involved

  • Asthma questionnaires
  • Review of changes in health or medications
  • Review of information in e-Diary
  • Limited physical examination
  • Electrocardiogram Temperature
  • Heart rate
  • Blood pressure
  • Breathing rate (seated) Bronchoscopy
  • Breathing test for fractional exhaled nitric oxide
  • Spirometry test Urine pregnancy test (if you can become pregnant) Blood sample (about 2 to 2 2/3 tablespoons [30-40 mL] at each visit) Study drug administration


You will be paid for each visit that you complete. If you complete all study visits, you will be paid up to $1150 for taking part in this study.

Contact Information

Study Coordinator
Bob Hmieleski
Principal Investigator
Dr. Eugene Bleecker

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.